AMY ROBERTS: Open Payments
NPI 1154302628 · RICHLANDS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 14 payments from 8 companies in 2025. Trend: 2023 $922 · 2024 $700 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $63 |
| Lilly USA, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| Abbott Laboratories | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Ardelyx, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, Ozempic, CAPLYTA, UBRELVY, IBSRELA, Wegovy, Rybelsus.
Industry payments across VA — which companies pay providers there.
